Literature DB >> 25697386

Endobronchial biopsies on aspirin and prasugrel.

Kassem Harris1, Jad Kebbe2.   

Abstract

Patients are generally required to stop antiplatelet therapy prior to elective invasive procedures. Some patients receive dual antiplatelet therapy for recent vascular procedures such as drug-eluting coronary stenting, and early discontinuation of antiplatelet agents could lead to a significant risk of stent thrombosis. Most bronchoscopic procedures are performed on patients using Aspirin but not on those using Clopidogrel or Prasugrel. In this report, we describe a unique case of a patient with a recent placement of drug-eluting stents, who required endobronchial biopsies for evaluation of lung cancer recurrence. The procedure was performed successfully and safely with no complications.
Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aspirin; Bleeding; Bronchoscopy; Endobronchial biopsy; Prasugrel

Mesh:

Substances:

Year:  2015        PMID: 25697386     DOI: 10.1016/j.hlc.2015.01.009

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  2 in total

1.  Aspirin use and the risk of bleeding complications after therapeutic bronchoscopy.

Authors:  Kassem Harris; Jad Kebbe; Kush Modi; Abdul Hamid Alraiyes; Abhishek Kumar; Kristopher Attwood; Samjot S Dhillon
Journal:  Ther Adv Respir Dis       Date:  2016-05-10       Impact factor: 4.031

Review 2.  Management of oral antiplatelet agents and anticoagulation therapy before bronchoscopy.

Authors:  Houssein A Youness; Jean Keddissi; Ilya Berim; Ahmed Awab
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.